Envision Pharma Group completed the acquisition of OKRA.ai.

Envision Pharma Group, a technology-enabled commercialization, and data analytics company, completed the acquisition of OKRA.ai, a technology company active in the provision of artificial intelligence solutions. Financial terms were not disclosed. "We are delighted to welcome OKRA.ai into the Envision Pharma Group family. The acquisition of OKRA.ai marks an exciting milestone in Envision's evolution as we continue to accelerate and deliver a compelling combination of technology-enabled capabilities and solutions to clients. The combination of Envision's leading technology, capabilities, and solutions with OKRA.ai's artificial intelligence solutions and expertise enables us to strengthen our offerings to clients across the product life cycle, but more importantly, support patients in their journey to health and wellness," Meg Heim, Envision Pharma Group CEO.